Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

2.

Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Winblad B, Hill S, Beermann B, Post SG, Wimo A.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:39-45. No abstract available.

PMID:
9305515
3.

Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Whitehouse PJ, Orgogozo JM, Becker RE, Gauthier S, Pontecorvo M, Erzigkeit H, Rogers S, Mohs RC, Bodick N, Bruno G, Dal-Bianco P.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:56-60. No abstract available.

PMID:
9305519
4.

Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997.

Harvey RJ, Whitehouse PJ, Rossor MN.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):259-61.

PMID:
9876953
5.

Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Antuono P, Doody R, Gilman S, Huff J, Scheltens P, Ueda K, Khachaturian ZS.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:22-5.

PMID:
9305510
6.

Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.

Harvey RJ, Sciulli CG, Mason RM, Whitehouse PJ.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:29-32. No abstract available.

PMID:
9305512
7.

Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Gauthier S, Bodick N, Erzigkeit E, Feldman H, Geldmacher DS, Huff J, Mohs R, Orgogozo JM, Rogers S.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:6-7. No abstract available.

PMID:
9305507
8.

Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Feldman H, Anand R, Blesa R, Dubois B, Gray J, Homma A, Mohr E, Morris JC, Parys W, Raschig A, Robillard A.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:61-4. No abstract available.

PMID:
9305520
9.

Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Ferris SH, Lucca U, Mohs R, Dubois B, Wesnes K, Erzigkeit H, Geldmacher D, Bodick N.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:34-8. No abstract available.

PMID:
9305514
10.

Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Post SG, Beerman B, Brodaty H, Gaines AW, Gauthier SG, Geldmacher DS, Hill S, Homma A, Rossor MN, Whitehouse PJ, Winblad B.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:26-8. No abstract available.

PMID:
9305511
11.
12.

The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.

Whitehouse PJ.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:2-5. No abstract available.

PMID:
9305506
13.

2nd Asia-Pacific regional meeting of the International Working Group on Harmonization of Dementia Drug Guidelines: meeting report.

Auchus AP, Chen CP; International Working Group on Harmonization of Dementia Drug Guidelines..

Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):129-31.

PMID:
12794392
14.

Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Homma A, Brodaty H, Bruno G, Cummings JL, Gilman S, Gracon S, McKeith IG.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:54-5. No abstract available.

PMID:
9305518
15.

Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, Shimohama S, Silber C.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:46-9. No abstract available.

PMID:
9305516
16.

Harmony and consensus: cultural aspects of organization in international science.

Gaines AD, Whitehouse PJ.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):295-301. Review.

PMID:
9876957
17.

Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines.

Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, Xu XH.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):263-5. No abstract available.

PMID:
9876954
18.

Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, Kumar R, Lucca U, Mangone CA, Mohr E, Morris JC, Rogers S, Sawada T.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:8-18.

PMID:
9305508
19.

Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:19-21. No abstract available.

PMID:
9305509
20.

Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.

Bodick N, Forette F, Hadler D, Harvey RJ, Leber P, McKeith IG, Riekkinen PJ, Rossor MN, Scheltens P, Shimohama S, Spiegel R, Tanaka S, Thal LJ, Urata Y, Whitehouse P, Wilcock G.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:50-3.

PMID:
9305517

Supplemental Content

Support Center